Penumbra, Inc. (PEN): Price and Financial Metrics

Penumbra, Inc. (PEN): $259.69

-1.33 (-0.51%)

POWR Rating

Component Grades














  • PEN scores best on the Growth dimension, with a Growth rank ahead of 79.49% of US stocks.
  • PEN's strongest trending metric is Growth; it's been moving up over the last 177 days.
  • PEN ranks lowest in Momentum; there it ranks in the 17th percentile.

PEN Stock Summary

  • PENUMBRA INC's market capitalization of $9,862,637,704 is ahead of 83.27% of US-listed equities.
  • With a price/sales ratio of 11.88, PENUMBRA INC has a higher such ratio than 90.12% of stocks in our set.
  • In terms of twelve month growth in earnings before interest and taxes, PENUMBRA INC is reporting a growth rate of -230.97%; that's higher than just 6.68% of US stocks.
  • Stocks that are quantitatively similar to PEN, based on their financial statements, market capitalization, and price volatility, are VERX, TRIP, NARI, KRUS, and TTWO.
  • Visit PEN's SEC page to see the company's official filings. To visit the company's web site, go to

PEN Valuation Summary

  • In comparison to the median Healthcare stock, PEN's price/sales ratio is 442.86% higher, now standing at 11.4.
  • Over the past 90 months, PEN's price/sales ratio has gone up 3.1.

Below are key valuation metrics over time for PEN.

Stock Date P/S P/B P/E EV/EBIT
PEN 2023-01-30 11.4 9.8 -311.2 -219.3
PEN 2023-01-27 11.5 9.8 -311.7 -219.7
PEN 2023-01-26 11.2 9.5 -304.4 -214.7
PEN 2023-01-25 10.9 9.3 -297.3 -209.7
PEN 2023-01-24 11.1 9.5 -303.2 -213.8
PEN 2023-01-23 11.5 9.8 -312.0 -219.9

PEN Growth Metrics

    Its 2 year net income to common stockholders growth rate is now at -116.52%.
  • Its 3 year net income to common stockholders growth rate is now at -154.82%.
  • Its 5 year cash and equivalents growth rate is now at -34.78%.
PEN's revenue has moved up $409,732,000 over the prior 49 months.

The table below shows PEN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 829.928 -66.268 -30.512
2022-06-30 806.367 -16.909 -19.391
2022-03-31 782.281 19.356 -6.473
2021-12-31 747.59 9.502 5.284
2021-09-30 710.477 16.689 33.565
2021-06-30 671.436 -23.311 15.9

PEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PEN has a Quality Grade of C, ranking ahead of 49.95% of graded US stocks.
  • PEN's asset turnover comes in at 0.794 -- ranking 38th of 186 Medical Equipment stocks.
  • IVC, NTUS, and MLSS are the stocks whose asset turnover ratios are most correlated with PEN.

The table below shows PEN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.794 0.618 0.009
2021-03-31 0.728 0.610 -0.030
2020-12-31 0.728 0.603 -0.054
2020-09-30 0.738 0.635 -0.038
2020-06-30 0.774 0.658 0.017
2020-03-31 0.880 0.676 0.079

PEN Price Target

For more insight on analysts targets of PEN, see our PEN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $319.80 Average Broker Recommendation 1.31 (Strong Buy)

PEN Stock Price Chart Interactive Chart >

Price chart for PEN

PEN Price/Volume Stats

Current price $259.69 52-week high $266.63
Prev. close $261.02 52-week low $114.86
Day low $256.14 Volume 133,400
Day high $261.69 Avg. volume 307,704
50-day MA $227.94 Dividend yield N/A
200-day MA $177.40 Market Cap 9.86B

Penumbra, Inc. (PEN) Company Bio

Penumbra Inc. is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. The company was founded in 2004 and is based in Alameda, CA.

PEN Latest News Stream

Event/Time News Detail
Loading, please wait...

PEN Latest Social Stream

Loading social stream, please wait...

View Full PEN Social Stream

Latest PEN News From Around the Web

Below are the latest news stories about PENUMBRA INC that investors may wish to consider to help them evaluate PEN as an investment opportunity.

Catalent (CTLT) to Report Q2 Earnings: What's in the Cards?

Catalent's (CTLT) Q2 results are likely to have been driven by robust segmental performances.

Yahoo | February 3, 2023

4 Low-Beta Stocks to Buy to Sail Through the Volatile Market

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Penumbra (PEN), Patria Investments (PAX), Lamb Weston (LW) and BJ's Wholesale (BJ) are poised to gain.

Yahoo | January 31, 2023

Investing in Penumbra (NYSE:PEN) five years ago would have delivered you a 160% gain

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...

Yahoo | January 29, 2023

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 23, 2023

Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2022 after market close on Thursday, February 23, 2023 at 4:30 PM Eastern Time. A press release with fourth quarter and full year 2022 financial results will be issued after market close that day.

Yahoo | January 26, 2023

Penumbra – Consensus Indicates Potential 2.7% Upside

Penumbra found using ticker (PEN) now have 10 analysts covering the stock. The analyst consensus points to a rating of ''Strong_Buy''. The range between the high target price and low target price is between 270 and 195 calculating the mean target price we have 246. With the stocks previous close at 239.51 this now indicates there is a potential upside of 2.7%. The day 50 moving average is 211.43 and the 200 day moving average is 174.74. The market capitalisation for the company is $9,102m. You can visit the company''s website by visiting: [stock_market_widget type="chart" template="basic" color="green" assets="PEN" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $9,349m based on the market concensus. Penumbra de...

DirectorsTalk | January 20, 2023

Read More 'PEN' Stories Here

PEN Price Returns

1-mo 12.69%
3-mo 47.55%
6-mo 52.89%
1-year 17.00%
3-year 47.26%
5-year 190.81%
YTD 16.74%
2022 -22.57%
2021 64.18%
2020 6.53%
2019 34.43%
2018 29.86%

Continue Researching PEN

Here are a few links from around the web to help you further your research on Penumbra Inc's stock as an investment opportunity:

Penumbra Inc (PEN) Stock Price | Nasdaq
Penumbra Inc (PEN) Stock Quote, History and News - Yahoo Finance
Penumbra Inc (PEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7806 seconds.